⌘K

Home/Filings/4/0000899243-18-024025

4//SEC Filing

Aivado Manuel 4

Accession 0000899243-18-024025

CIK 0001420565other

View on SEC.gov Company Profile

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 5:47 PM ET

Size

5.4 KB

Accession

0000899243-18-024025

Insider Transaction Report

Form 4

Period: 2018-09-06

AILERON THERAPEUTICS INCALRN

Director

Transactions

Award
Stock Option (right to buy)
2018-09-06+232,914→ 232,914 total
Exercise: $3.39Exp: 2028-09-05→ Common Stock (232,914 underlying)

Footnotes (1)

[F1]This option was granted on September 6, 2018. The shares underlying the option are scheduled to vest in equal monthly installments over four years from September 6, 2018.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AILERON THERAPEUTICS INC

CIK 0001420565

Entity typeother

Related Parties

1

filerCIK 0001709603

Filing Metadata

Form type: 4
Filed: Sep 6, 8:00 PM ET
Accepted: Sep 7, 5:47 PM ET
Size: 5.4 KB

View on SEC.gov